Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 1/20 | 1.00 |
| ▸ | CA4 | P22748 | 1/20 | 1.00 |
| ▸ | JUN | P05412 | 1/20 | 0.73 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 4/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | BCHE | P06276 | 1/20 | 0.63 |
| ▸ | GUSB | P08236 | 1/20 | 0.63 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.58 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.56 |
| ▸ | TNKS | O95271 | 1/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| O-Coumaric Acid SCHEMBL64885 | 1.00 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL64886 | 1.00 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL29353381 | 1.00 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL29367602 | 1.00 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL29368085 | 1.00 | NFKB1 (1.00) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL1221495 | 0.98 | NFKB1 (0.96) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL8719132 | 0.98 | NFKB1 (0.96) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL8719129 | 0.98 | NFKB1 (0.96) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL28048519 | 0.98 | NFKB1 (0.96) | NFKB1CA1CA2CA4JUN | |
| O-Coumaric Acid SCHEMBL28048517 | 0.98 | NFKB1 (0.96) | NFKB1CA1CA2CA4JUN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| US-20220026398-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2022-01-27 | — | — | US | claimed |
| US-20130155361-A1 | DISPLAY PANEL AND MANUFACTURING METHOD THEREOF AND IMAGE DISPLAY SYSTEM | CHIMEI INNOLUX CORPORATION (TW) | 2013-06-20 | — | — | US | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | disclosed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260101892-A1 | METHOD TO INHIBIT PROLIFERATION OF A PHYTOPATHOGEN ON PLANTS AND COMPOSITIONS USED FOR THIS PURPOSE | CYSBIO APS (DK) | 2026-04-16 | — | — | US | disclosed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | disclosed |
| CN-113773309-B | Coumarin pyridinium compound and application thereof | 华东理工大学 | 2024-07-09 | — | — | CN | disclosed |
| CN-118044994-A | Application of hydroxy cinnamic acid, isoamyl acetate or betaine in preparation of composition | 株式会社LG生活健康 | 2024-05-17 | — | — | CN | disclosed |
| CN-112004516-B | Composition for improving skin barrier dysfunction | 株式会社LG生活健康 | 2024-03-12 | — | — | CN | disclosed |
| US-20090124688-A1 | Prostaglandin reductase inhibitors | ABGENOMICS CORPORATION (TW) | 2009-05-14 | — | — | US | disclosed |
| US-20070214517-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | CERES, INC. (US) | 2007-09-13 | — | — | US | disclosed |
| WO-2007082178-A2 | PROSTAGLANDIN REDUCTASE INHIBITORS | ABGENOMICS CORPORATION (TW) | 2007-07-19 | — | — | WO | disclosed |
| US-20060150283-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | ALEXANDROV NICKOLAI | 2006-07-06 | — | — | US | disclosed |
| US-20060048240-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | ALEXANDROV NICKOLAI | 2006-03-02 | — | — | US | disclosed |
| US-4691040-A | ANTIHISTAMINES, ANTIALLERGENS, HALIDES, SULFONATES, PYRROLIDINE | HOFFMANN-LA ROCHE INC. (US) | 1987-09-01 | — | — | US | disclosed |
| US-4681954-A | 7,8,9,10-tetrahydro-6-oxo-6H-dibenzo(b,d)pyranyloxy-propanes | PENNWALT CORPORATION (US) | 1987-07-21 | — | — | US | disclosed |
| EP-0221293-A1 | 7,8,9,10-Tetrahydro-6-oxo-6H-dibenzo[b,d]pyranyloxy-propanes | PENNWALT CORPORATION (US) | 1987-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260101892-A1 | METHOD TO INHIBIT PROLIFERATION OF A PHYTOPATHOGEN ON PLANTS AND COMPOSITIONS USED FOR THIS PURPOSE | HAAO, NOTUM, WEE1 | NFKB1 1543/4885CA1 776/4885CA2 1323/4885 |
| US-20070214517-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | RNGTT, CPSF1, CPSF6 | NFKB1 3784/4885CA1 3891/4885CA2 3833/4885 |
| US-20090124688-A1 | Prostaglandin reductase inhibitors | PTGIR, PTGDR, PTGDR2 | NFKB1 1400/4885CA1 4565/4885CA2 3030/4885 |
| US-20060048240-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | RNGTT, CPSF1, CPSF6 | NFKB1 3784/4885CA1 3891/4885CA2 3833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.